BASF to Lift Chinese Tertiary Butylamine Output

BASF has announced it will expand output capability of its world-scale production plant for tertiary Butylamine (tBA) at the Nanjing Chemical Industry Park in China by 60%.

Under the plan, capacity will rise from 10,000 t/y at present to 16,000 t/y by 2015, provided regulatory authorities approve.

BASF said the additional capability for the primary aliphatic amine used as an intermediate in production of accelerators for the rubber and tire industry as well as a building block for pharmaceuticals and agrochemicals will "further strengthen" its leading position as a global supplier to the rubber and tire industry.

"The expansion will enable us to continue meeting the notably increased demand of our customers in Asia, especially China, reliably out of our local assets in China," said Guido Voit, senior vice president, BASF Intermediates Asia Pacific.

In addition to Nanjing, BASF produces tBA in Geismar, Louisiana, and in Antwerp, Belgium.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read